Concorde Clinical Trials
Concorde Medical Group’s Clinical Trials Program is actively recruiting patients for several research trials. Patients who participate in these trials assist in the advancement of medical science, gain access to cutting-edge treatments, may be eligible to receive medications at no cost, and may receive monetary reimbursement for participation
To learn more about any one of the clinical research trials listed below, please contact Research Study Coordinator, Maureen Haskins at 212-889-5544 ext 152 or e-mail: .(JavaScript must be enabled to view this email address)
ULCERATIVE PROCTITIS
Ulcerative Proctitis is a mild form of ulcerative colitis, an inflammatory bowel disease that affects as many as half a million Americans and results in 20,000 hospitalizations a year. Symptoms include diarrhea, rectal bleeding and abdominal cramping. Ulcerative Proctitis can significantly worsen one’s quality of life.
Concorde Medical Group is currently participating in a clinical trial evaluating an investigational steroid foam for the treatment of Ulcerative Proctitis.
The study lasts for 56 days and consists of 6 office visits. Participants who complete the study will receive monetary compensation. Study participants will receive the study medication and study-related exams at no cost.
In This Section
Central Business Office's
Customer Service hours are
Monday-Friday 9-12PM and 2-3PM
Physician Referral line
Phone: (212) 614-9489
Ask A Provider
Patient Satisfaction Survey
